Abstract
Objective Dengue infection is a significant health issue in tropical areas over the globe. Physiological changes of pregnancy can be confounding the clinical presentation of dengue in pregnancy. This study aimed to investigate the adverse outcomes of antenatal dengue infection and factors associated with maternal, fetal, and neonatal complications.
Methods A total of 115 pregnant women with laboratory-confirmed dengue infection admitted to two tertiary referral hospitals in Sri Lanka were followed from admission until delivery and discharge. Data on clinical and laboratory outcome variables were collected and analyzed using descriptive and inferential statistics.
Results Dengue fever accounted for the majority of cases (63.5%), followed by dengue hemorrhagic fever (33.9%) and, dengue expanded syndrome (2.6%). Maternal adverse outcomes were observed in 27.8% of cases with 19.1% of ICU admissions. Dengue category, trimester of infection, platelet count, and AST levels showed a significant association with adverse maternal outcomes. Fetal adverse outcomes affected 8.1% of cases, while neonatal adverse outcomes occurred in 28.7% of live births, with transplacental transmission observed in two cases.
Conclusion Dengue infection during pregnancy can lead to significant maternal, fetal, and neonatal morbidity and mortality. Identifying risk factors may help predict the severity of these outcomes. Further research is needed to develop robust prediction models and improve management strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics Review Committee, Faculty of Medicine, University of Colombo, Sri Lanka. EC-18-024
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
oshadhinallaperuma{at}gmail.com, senanayakeh{at}gmail.com, janakagode{at}gmail.com
Postal address -Geethani, Udukawa, Denipitiya, Sri Lanka
There are no conflict of interests and this study has been self-funded by the researchers. The study has received approval from the Ethics Review Committee of the Faculty of Medicine, University of Colombo, Sri Lanka (EC/18/024).
The title has been updated to better reflect the nature of the study and minor adjustments has been made to the body of the article to match the submitted peer review journal guidelines.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
